ARID3A and systemic lupus erythematosus: When HSPCs from SLE patients were transplanted into immunodeficient mice, the engraftment and development were similar between the samples with low numbers of ARID3a-expressing cells and those with high numbers of ARID3a-expressing cells [71], suggesting that ARID3a over-expression does not affect engraftment potential.